Marketing authorisation for a medicine Medical devices Application for general reimbursement Inspection of pharmaceutical companies Company authorisations and registrations DKMAnet Clinical trials of medicines Fees Product defects and withdrawals
Theme

Strategy for the DKMA

The Danish Medicines Agency has formulated a strategy for 2022-26. The strategy emphasizes a vision of leading the way in national and international cooperation, and in the dialogue with citizens and society. Read more.

Go to theme
Theme

Vaccines and medicines against COVID-19

Read about the current studies and development of vaccines and medicines for treatment of COVID-19, and how medicines can be approved much quicker in extraordinary situations, if patient safety is sufficiently assured.

Go to theme

News and notifications

EMA’s Human Medicines Committee Recommends Wegovy in Tablet Form

22 May 2026

EMA’s human medicines committee (CHMP), part of the European Medicines Agency, decided at its meeting this week to recommend approval of Wegovy in tablet form. It is now for the European Commission to make the final decision.

Operation Pangea XVIII: Global action against falsified medicines and illicit trade

07 May 2026

PRAC assesses that NAION could be a very rare side effect of Ozempic, Rybelsus and Wegovy

19 March 2026

Electronic dispatch of decision letters marks its fifth anniversary

04 February 2026